valine has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, MA; Birkinshaw, RW; Blombery, P; Chen, X; Conway, T; Czabotar, PE; Gong, JN; Huang, DCS; McBean, M; Nguyen, T; Roberts, AW; Seymour, JF; Thijssen, R; Thompson, ER; Westerman, DA | 1 |
Gari-Toussaint, M; Roux, C; Thyss, A | 1 |
Skinnider, B; Villa, D | 1 |
Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S | 1 |
Smolej, L | 1 |
5 other study(ies) available for valine and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.
Topics: Amino Acid Substitution; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cohort Studies; Disease Progression; DNA Mutational Analysis; Drug Resistance, Neoplasm; Gene Frequency; Glycine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Models, Molecular; Mutation; Mutation Rate; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; Valine | 2020 |
Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
Topics: Abscess; Acyclovir; Alemtuzumab; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephritis; Prostatitis; Salvage Therapy; Valacyclovir; Valine; Voriconazole | 2013 |
Herpes simplex virus lymphadenitis.
Topics: Acyclovir; Antibodies, Viral; Biopsy; Herpesviridae Infections; Humans; Immunoglobulin G; Immunohistochemistry; Immunosuppression Therapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphadenitis; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine | 2014 |
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine | 2015 |
Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
Topics: Acyclovir; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Valacyclovir; Valganciclovir; Valine | 2008 |